Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine. Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work. Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders. Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy. Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine. Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy. Recent News Articles and Media Coverage Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019). Dr. Boudadi is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Glioma, Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Gastrointestinal Stromal Tumor, and Prostatectomy.

Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland. Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health. Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation. Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly. Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet. Recent News Articles and Media Coverage Bladder cancer trends in Montgomery and Prince George's counties: Welcome news - and 3 facts you need to know. NJ.com (08/16/2016) RCCA Expands to Maryland to Become One of the Nation's First Multi-State Oncology/Hematology Physician-Owned and -Operated Networks. OncLive (10/06/2015). Dr. Boccia is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Anemia, Multiple Myeloma, Thrombocytopenia, Adult Immune Thrombocytopenia, and Splenectomy.

"Dr. Ari D. Fishman is a hematologist affiliated with Sibley Memorial Hospital, Holy Cross Hospital and George Washington University Hospital, where he serves as an assistant professor of medicine for the School of Medicine. He practices out of Maryland Oncology and Hematology, located in Wheaton, Maryland and Silver Spring, Maryland. Dr. Fishman earned his medical degree from Sackler School of Medicine. He completed a residency in internal medicine at the Beth Israel Medical Center, followed by a fellowship in hematology and oncology at the Montefiore Medical Center. Dr. Fishman previously worked at Washington Oncology Hematology Center, located in Washington, D.C. and Chevy Chase, Maryland. Dr. Fishman has been named a Top Doctor in Hematology and Oncology by Washingtonian Magazine and a Top Doctor by Consumers’ Checkbook magazine. Dr. Fishman is a member of the American College of Physicians and the American Society of Clinical Oncology. Dr. Fishman has contributed to numerous publications. Selected Publications Fishman AD, Hoffman A, Volterra F, Frymus M, Gentilluci M. ""Intracaval and intracardiac metastatic nonseminomatous germ cell tumor: a rare cause of hemolytic anemia and thrombocytopenia."" Cancer Invest. 2002;20(7-8):996-1001.". Dr. Fishman is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome (MDS), and Childhood Iron Deficiency Anemia.

Victor Priego is a Hematologist Oncology specialist and an Oncologist in Bethesda, Maryland. Dr. Priego is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Myelodysplastic Syndrome (MDS), Anemia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Splenectomy.

Theodore Li is a primary care provider, practicing in Internal Medicine in Washington, Washington, D.c.. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Chronic Cough, Fainting, Hypothyroidism, and Obesity in Children.

Christin Destefano is a Hematologist Oncology specialist and a Hematologist in Bethesda, Maryland. Dr. Destefano is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, and Hereditary Ovalocytosis.

Chitra Rajagopal is a Hematologist Oncology specialist and a Hematologist in Bethesda, Maryland. Dr. Rajagopal is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Breast Cancer. Dr. Rajagopal is currently accepting new patients.

Nelson Kalil is a Hematologist Oncology specialist and a Hematologist in Rockville, Maryland. Dr. Kalil is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Protein S Deficiency, Hereditary Resistance to Anti-Vitamin K, Congenital Antithrombin 3 Deficiency, and Protein C Deficiency. Dr. Kalil is currently accepting new patients.

Scott Rowley is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Rowley is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.

Syed Mahmood is a Hematologist and a Hematologist Oncology provider in Rockville, Maryland. Dr. Mahmood is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Thrombocytopenia, RUNX1 Familial Platelet Disorder, Colorectal Cancer, and Lynch Syndrome.

John Wallmark is a Hematologist Oncology provider in Rockville, Maryland. Dr. Wallmark is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Multiple Myeloma, and Colorectal Cancer.

"George A. Sotos, M.D., is the chief of hematology and oncology at Suburban Hospital, as well as a member of Suburban's Cancer Committee and the coordinator of Multidisciplinary Cancer Conferences. Dr. Sotos is a partner of Maryland Oncology & Hematology in Rockville, Maryland. Dr. Sotos has expertise in medical oncology and hematology, as well as chemotherapy. Dr. Sotos earned his Master of Science in Physiology from Georgetown University, followed by his medical degree from the Medical College of Virginia. He completed a residency in internal medicine with University of Texas Southwestern Medical Center, followed by a fellowship in medical oncology with the National Cancer Institute of the National Institutes of Health. Dr. Sotos is a fellow of the American College of Physicians, as well as a member of the Montgomery County Medical Society, the Medical and Chirurgical Faculty of the State of Maryland, and the American Society of Clinical Oncology. He is also a member of the oncology specialty panel for Johns Hopkins Medicine's Formulary Management Committee and previously served as a member of Suburban Hospital's Medical Staff Executive Committee, Provider Quality Committee and Physician Advisory Board. Dr. Sotos has been named a Top Doctor by Washington Consumers' Checkbook and a Super Doctor by the Washington Post magazine. Castle Connolly has also named him a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas. Dr. Sotos has contributed to numerous publications on medical oncology and hematology topics. Selected Publications Rotello, L, Albrant, D, Nossuli, K, Sotos, G, Samet, C, Rainey, T. ""Impact of a Hospital-Wide Pharmacy Implemented Weight-Based Dosing Protocol for Erythropoietin."" Chest, 124:4 (Suppl):182S (Abstract), 2003. Sotos, George A. ""Ars Brevis."" Journal of Clinical Oncology, 2013; 31:14; 1792-1794; http://jco.ascopubs.org/content/31/14/1792.full.pdf+html". Dr. Sotos is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Multiple Myeloma, and Endometrial Cancer.

Craig Kessler is a Hematologist in Washington, Washington, D.c.. Dr. Kessler is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Blood Clots, Hemophilia A, Acquired Hemophilia, Bone Marrow Aspiration, and Splenectomy.

Catherine Broome is a Hematologist in Washington, Washington, D.c.. Dr. Broome is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Autoimmune Hemolytic Anemia, Chronic B-Cell Leukemia (CBCL), Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Ajoy Dias is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Dias is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Julia Cunningham is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Cunningham is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Thrombocytopenia, Essential Thrombocythemia, Adult Immune Thrombocytopenia, Pulmonary Embolism, and Bone Marrow Aspiration. Dr. Cunningham is currently accepting new patients.

Ekatherine Asatiani is a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Asatiani is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Myelofibrosis, Anemia, and Cholangiocarcinoma (Bile Duct Cancer).

Vera Malkovska is a Hematologist in Washington, Washington, D.c.. Dr. Malkovska is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. Her top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Sickle Cell Disease, and Bone Marrow Aspiration.